GrafTech Reports Fourth Quarter and Full Year 2022 Results
GrafTech International Ltd. (NYSE: EAF) reported fourth quarter and full year 2022 financial results, showcasing significant challenges. In Q4 2022, net income was $50 million with an EPS of $0.20, down from $141 million and $0.54 in Q4 2021. Full-year net income stood at $383 million, slightly lower than $388 million in 2021. Sales volume decreased by 37% year-over-year in Q4 due to operational suspensions in Monterrey, Mexico. Adjusted EBITDA dropped to $80 million in Q4, reflecting rising costs and softer demand. Looking ahead, GrafTech anticipates lower sales due to ongoing economic uncertainty and expects production ramp-up post-suspension. The company aims to manage costs effectively during this period.
- Reduced debt by $110 million in 2022.
- Cash flow from operating activities was $325 million for 2022.
- Net income decreased by 64% in Q4 2022 compared to Q4 2021.
- Sales volume in Q4 2022 fell by 37% year-over-year, impacting revenue.
- Adjusted EBITDA decreased to $80 million in Q4 2022 from $183 million in Q4 2021.
- Expectations of significant decline in sales volume for the first half of 2023.
Fourth Quarter Results and 2023 Outlook Reflect Near-term Challenges in the Operating Environment
Taking Actions to Optimally Position GrafTech to Benefit from Long-term Industry Growth
Restarted Operations at
Fourth Quarter 2022 Highlights
-
Net income of
, for a$50 million 20% net income margin -
Earnings per share ("EPS")(1) of
and adjusted EPS(1)(2) of$0.20 $0.17 -
Adjusted EBITDA(2) of
, for a$80 million 32% adjusted EBITDA margin(3) - Sales volume of 28 thousand metric tons ("MT")
- Production volume of 29 thousand MT
-
Cash flow from operating activities of
$50 million
Full Year 2022 Highlights
-
Net income of
, for a$383 million 30% net income margin -
EPS(1) of
per share and adjusted EPS(1)(2) of$1.48 $1.47 -
Adjusted EBITDA(2) of
, for a$536 million 42% adjusted EBITDA margin(3) - Sales volume of 149 thousand MT
- Production volume of 157 thousand MT
-
Cash flow from operating activities of
$325 million -
Reduced debt by
$110 million -
Repurchased an aggregate of
of our common stock$60 million
CEO Comments
"Our year-over-year performance for the fourth quarter was impacted by higher costs, softer industry demand and the impact of the temporary suspension of our operations in
"We remain disciplined in our approach to managing costs and allocating capital," said
Fourth Quarter and Full Year 2022 Financial Performance
(dollars in thousands, except per share amounts) |
|
|
Year Ended |
|||||||||
|
|
|||||||||||
Q4 2022 |
Q3 2022 |
Q4 2021 |
|
2022 |
2021 |
|||||||
Net sales |
$ |
247,519 |
$ |
303,840 |
$ |
363,293 |
|
$ |
1,281,250 |
$ |
1,345,788 |
|
Net income |
$ |
50,331 |
$ |
93,451 |
$ |
141,480 |
|
$ |
382,962 |
$ |
388,330 |
|
EPS(1) |
$ |
0.20 |
$ |
0.36 |
$ |
0.54 |
|
$ |
1.48 |
$ |
1.46 |
|
Cash flow from operating activities |
$ |
50,023 |
$ |
68,166 |
$ |
100,029 |
|
$ |
324,628 |
$ |
443,040 |
|
|
|
|
|
|
|
|
||||||
Adjusted net income(2) |
$ |
44,761 |
$ |
93,883 |
$ |
131,180 |
|
$ |
379,666 |
$ |
464,585 |
|
Adjusted EPS(1)(2) |
$ |
0.17 |
$ |
0.37 |
$ |
0.50 |
|
$ |
1.47 |
$ |
1.74 |
|
Adjusted EBITDA(2) |
$ |
80,101 |
$ |
128,567 |
$ |
182,817 |
|
$ |
536,464 |
$ |
669,940 |
|
Adjusted free cash flow(2) |
$ |
23,139 |
$ |
52,233 |
$ |
86,857 |
|
$ |
252,906 |
$ |
456,160 |
Net sales for the fourth quarter of 2022 were
Net income for the fourth quarter of 2022 was
For the fourth quarter of 2022, cash flow from operating activities was
For the year ended
Operational and Commercial Update
Key Operating Metrics |
|
|
|
|
Year Ended |
||||||
|
|
|
|
|
|||||||
(in thousands, except percentages) |
Q4 2022 |
Q3 2022 |
Q4 2021 |
|
2022 |
2021 |
|||||
Sales volume (MT)(4) |
27.8 |
|
35.7 |
|
44.2 |
|
|
149.1 |
|
167.4 |
|
Production volume (MT)(5) |
29.4 |
|
37.7 |
|
46.2 |
|
|
157.1 |
|
165.2 |
|
Total production capacity (MT)(6)(7) |
59.0 |
|
55.0 |
|
59.0 |
|
|
230.0 |
|
230.0 |
|
Total capacity utilization(7)(8) |
50 |
% |
69 |
% |
78 |
% |
|
68 |
% |
72 |
% |
Production capacity excluding |
52.0 |
|
48.0 |
|
52.0 |
|
|
202.0 |
|
202.0 |
|
Capacity utilization excluding |
57 |
% |
79 |
% |
88 |
% |
|
78 |
% |
82 |
% |
Sales volume for the fourth quarter of 2022 was 28 thousand MT, a decrease of
For the fourth quarter of 2022, the weighted-average realized price for our LTA volume was
Production volume for the fourth quarter of 2022 was 29 thousand MT, a decrease of
For the year ended
Steel market capacity utilization rates have been as follows:
|
Q4 2022 |
Q3 2022 |
Q4 2021 |
|||
Global (ex- |
61 |
% |
64 |
% |
72 |
% |
|
73 |
% |
78 |
% |
82 |
% |
The table of estimated shipments of graphite electrodes under existing LTAs has been updated as follows to reflect our current expectations(12):
|
|
2023 |
|
2024 |
Estimated LTA volume (in thousands of MT) |
|
27-32 |
|
13-16 |
Estimated LTA revenue (in millions) |
|
|
|
|
Capital Structure and Capital Allocation
As of
Outlook
As we enter 2023, we anticipate continued soft demand for graphite electrodes due to ongoing economic uncertainty and geopolitical conflict. In addition, we expect the suspension of our operations in
Reflecting these factors, we estimate our sales volume for the first six months of 2023 will be approximately half of the level reported in the same period of 2022, with the largest impact occurring in the first quarter. As we proceed into the second half of the year, we expect sales volume levels to recover, as we move past
In 2023, we expect a significant year-over-year increase in our cost of goods sold per metric ton as fixed costs will be recognized over a smaller volume base and reflecting the full year impact of higher raw material costs that increased throughout 2022. In response, we are closely managing all of our operating costs and capital expenditures, as well as our working capital levels. Towards the end of the fourth quarter of 2022, we began proactively reducing production at our European graphite electrode manufacturing facilities, to align our production volume with our current demand outlook.
Longer term, we remain confident that the steel industry’s accelerating efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We believe that the near-term actions we are taking, supported by an industry-leading position and our sustainable competitive advantages, will optimally position
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings conference call being held on
About
________________________
(1) |
EPS represents diluted earnings per share. Adjusted EPS represents diluted adjusted earnings per share. |
|
(2) |
A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
|
(3) |
Adjusted EBITDA margin is calculated as adjusted EBITDA divided by net sales (Q4 2022 adjusted EBITDA of |
|
(4) |
Sales volume reflects only graphite electrodes manufactured by us. |
|
(5) |
Production volume reflects graphite electrodes we produced during the period. |
|
(6) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
|
(7) |
Includes graphite electrode facilities in Calais, |
|
(8) |
Capacity utilization reflects production volume as a percentage of production capacity. |
|
(9) |
Our |
|
(10) |
Source: |
|
(11) |
Source: |
|
(12) |
As it relates to the conflict between |
|
(13) |
Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs. |
Cautionary Note Regarding Forward‑Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our most recent Annual Report on Form 10-K and other filings with the
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Non‑GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow and adjusted free cash flow are non-GAAP financial measures.
We define EBITDA, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA plus any pension and other post-employment benefit ("OPEB") plan expenses, adjustments for public offerings and related expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. Adjusted EBITDA margin is also a non-GAAP financial measure used by our management and our Board of Directors as supplemental information to assess the Company’s operational performance and is calculated as adjusted EBITDA divided by net sales. In addition, we believe adjusted EBITDA, adjusted EBITDA margin and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities. We also monitor the ratio of total debt to trailing twelve month adjusted EBITDA because we believe it is a useful and widely used way to assess our leverage.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses relating to our pension and OPEB plans;
- adjusted EBITDA does not reflect public offerings and related expenses;
-
adjusted EBITDA does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar; - adjusted EBITDA does not reflect stock-based compensation expense;
- adjusted EBITDA does not reflect the non‑cash write‑off of fixed assets;
- adjusted EBITDA does not reflect related party payable - Tax Receivable Agreement adjustments;
- adjusted EBITDA does not reflect Change in Control charges;
-
adjusted EBITDA does not reflect gains from the settlement of a value-added tax matter in
Brazil ; and - other companies, including companies in our industry, may calculate EBITDA, adjusted EBITDA and adjusted EBITDA margin differently, which reduces its usefulness as a comparative measure.
We define adjusted net income, a non‑GAAP financial measure, as net income or loss, excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted EPS, a non‑GAAP financial measure, as adjusted net income divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net income and adjusted EPS are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
Free cash flow and adjusted free cash flow, non-GAAP financial measures, are metrics used by our management and our Board of Directors to analyze cash flows generated from operations. We define free cash flow as net cash provided by operating activities less capital expenditures. We define adjusted free cash flow as free cash flow adjusted by payments of the Change in Control charges that were triggered as a result of the ownership of our largest stockholder falling below
In evaluating EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow and adjusted free cash flow, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliations presented below, other than the Change in Control charges. Our presentations of EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow and adjusted free cash flow should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow and adjusted free cash flow alongside other measures of financial performance and liquidity, including our net income, EPS and cash flow from operating activities, respectively, and other GAAP measures.
|
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
(Dollars in thousands, except per share data) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|||||
ASSETS |
|
|
|
|||||
Current assets: |
|
|
|
|||||
Cash and cash equivalents |
$ |
134,641 |
|
|
$ |
57,514 |
|
|
Accounts and notes receivable, net of allowance for doubtful accounts of |
|
145,574 |
|
|
|
207,547 |
|
|
Inventories |
|
447,741 |
|
|
|
289,432 |
|
|
Prepaid expenses and other current assets |
|
87,272 |
|
|
|
73,364 |
|
|
Total current assets |
|
815,228 |
|
|
|
627,857 |
|
|
Property, plant and equipment |
|
869,168 |
|
|
|
815,298 |
|
|
Less: accumulated depreciation |
|
350,022 |
|
|
|
313,825 |
|
|
Net property, plant and equipment |
|
519,146 |
|
|
|
501,473 |
|
|
Deferred income taxes |
|
11,960 |
|
|
|
26,187 |
|
|
|
|
171,117 |
|
|
|
171,117 |
|
|
Other assets |
|
86,727 |
|
|
|
85,684 |
|
|
Total assets |
$ |
1,604,178 |
|
|
$ |
1,412,318 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|||||
Current liabilities: |
|
|
|
|||||
Accounts payable |
$ |
103,156 |
|
|
$ |
117,112 |
|
|
Long-term debt, current maturities |
|
124 |
|
|
|
127 |
|
|
Accrued income and other taxes |
|
40,592 |
|
|
|
57,097 |
|
|
Other accrued liabilities |
|
89,349 |
|
|
|
56,405 |
|
|
Related party payable - Tax Receivable Agreement |
|
4,631 |
|
|
|
3,828 |
|
|
Total current liabilities |
|
237,852 |
|
|
|
234,569 |
|
|
Long-term debt |
|
921,803 |
|
|
|
1,029,561 |
|
|
Other long-term obligations |
|
50,822 |
|
|
|
68,657 |
|
|
Deferred income taxes |
|
45,065 |
|
|
|
40,674 |
|
|
Related party payable - Tax Receivable Agreement long-term |
|
10,921 |
|
|
|
15,455 |
|
|
Stockholders’ equity: |
|
|
|
|||||
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
Common stock, par value |
|
2,566 |
|
|
|
2,633 |
|
|
Additional paid-in capital |
|
745,164 |
|
|
|
761,412 |
|
|
Accumulated other comprehensive loss |
|
(8,070 |
) |
|
|
(7,444 |
) |
|
Accumulated deficit |
|
(401,945 |
) |
|
|
(733,199 |
) |
|
Total stockholders’ equity |
|
337,715 |
|
|
|
23,402 |
|
|
Total liabilities and stockholders’ equity |
$ |
1,604,178 |
|
|
$ |
1,412,318 |
|
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(Dollars in thousands, except per share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
Three Months Ended
|
|
Year Ended |
|||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
Net sales |
$ |
247,519 |
|
|
$ |
363,293 |
|
|
$ |
1,281,250 |
|
|
$ |
1,345,788 |
|
|
Cost of sales |
|
163,492 |
|
|
|
182,786 |
|
|
|
726,373 |
|
|
|
701,335 |
|
|
Gross profit |
|
84,027 |
|
|
|
180,507 |
|
|
|
554,877 |
|
|
|
644,453 |
|
|
Research and development |
|
1,024 |
|
|
|
801 |
|
|
|
3,641 |
|
|
|
3,771 |
|
|
Selling and administrative expenses |
|
19,115 |
|
|
|
17,666 |
|
|
|
76,977 |
|
|
|
132,608 |
|
|
Operating income |
|
63,888 |
|
|
|
162,040 |
|
|
|
474,259 |
|
|
|
508,074 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Other (income) expense, net |
|
(8,886 |
) |
|
|
(16,090 |
) |
|
|
(10,064 |
) |
|
|
(16,451 |
) |
|
Related party Tax Receivable Agreement expense (benefit) |
|
97 |
|
|
|
184 |
|
|
|
(83 |
) |
|
|
231 |
|
|
Interest expense |
|
11,533 |
|
|
|
14,551 |
|
|
|
36,568 |
|
|
|
68,760 |
|
|
Interest income |
|
(2,283 |
) |
|
|
(219 |
) |
|
|
(4,480 |
) |
|
|
(872 |
) |
|
Income before provision for income taxes |
|
63,427 |
|
|
|
163,614 |
|
|
|
452,318 |
|
|
|
456,406 |
|
|
Provision for income taxes |
|
13,096 |
|
|
|
22,134 |
|
|
|
69,356 |
|
|
|
68,076 |
|
|
Net income |
$ |
50,331 |
|
|
$ |
141,480 |
|
|
$ |
382,962 |
|
|
$ |
388,330 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Basic income per common share: |
|
|
|
|
|
|
|
|||||||||
Net income per share |
$ |
0.20 |
|
|
$ |
0.54 |
|
|
$ |
1.48 |
|
|
$ |
1.46 |
|
|
Weighted average common shares outstanding |
|
256,900,707 |
|
|
|
263,424,743 |
|
|
|
258,781,843 |
|
|
|
266,251,097 |
|
|
Diluted income per common share: |
|
|
|
|
|
|
|
|||||||||
Net income per share |
$ |
0.20 |
|
|
$ |
0.54 |
|
|
$ |
1.48 |
|
|
$ |
1.46 |
|
|
Weighted average common shares outstanding |
|
256,902,385 |
|
|
|
263,516,311 |
|
|
|
258,791,228 |
|
|
|
266,317,194 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||||||||||
(Dollars in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
Three Months Ended
|
|
Year Ended |
|||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
Cash flow from operating activities: |
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
50,331 |
|
|
$ |
141,480 |
|
|
$ |
382,962 |
|
|
$ |
388,330 |
|
|
Adjustments to reconcile net income to cash provided by operations: |
|
|
|
|
|
|
|
|||||||||
Depreciation and amortization |
|
13,788 |
|
|
|
17,301 |
|
|
|
55,496 |
|
|
|
65,716 |
|
|
Related party Tax Receivable Agreement expense (benefit) |
|
(83 |
) |
|
|
184 |
|
|
|
(83 |
) |
|
|
231 |
|
|
Deferred income tax provision |
|
5,806 |
|
|
|
2,523 |
|
|
|
17,022 |
|
|
|
(3,657 |
) |
|
Non-cash stock-based compensation expense |
|
645 |
|
|
|
338 |
|
|
|
2,311 |
|
|
|
16,631 |
|
|
Non-cash interest expense (benefit) |
|
675 |
|
|
|
2,301 |
|
|
|
(2,428 |
) |
|
|
12,051 |
|
|
Other adjustments |
|
(8,253 |
) |
|
|
323 |
|
|
|
(8,023 |
) |
|
|
7,107 |
|
|
Net change in working capital* |
|
2,047 |
|
|
|
(63,551 |
) |
|
|
(99,575 |
) |
|
|
(16,377 |
) |
|
Change in related-party Tax Receivable Agreement |
|
83 |
|
|
|
— |
|
|
|
(3,745 |
) |
|
|
(21,799 |
) |
|
Change in long-term assets and liabilities |
|
(15,016 |
) |
|
|
(870 |
) |
|
|
(19,309 |
) |
|
|
(5,193 |
) |
|
Net cash provided by operating activities |
|
50,023 |
|
|
|
100,029 |
|
|
|
324,628 |
|
|
|
443,040 |
|
|
Cash flow from investing activities: |
|
|
|
|
|
|
|
|||||||||
Capital expenditures |
|
(26,884 |
) |
|
|
(17,831 |
) |
|
|
(72,165 |
) |
|
|
(58,257 |
) |
|
Proceeds from the sale of assets |
|
34 |
|
|
|
41 |
|
|
|
195 |
|
|
|
397 |
|
|
Net cash used in investing activities |
|
(26,850 |
) |
|
|
(17,790 |
) |
|
|
(71,970 |
) |
|
|
(57,860 |
) |
|
Cash flow from financing activities: |
|
|
|
|
|
|
|
|||||||||
Debt issuance and modification costs |
|
— |
|
|
|
— |
|
|
|
(2,232 |
) |
|
|
(3,109 |
) |
|
Principal payments on long-term debt |
|
(124 |
) |
|
|
(100,142 |
) |
|
|
(110,124 |
) |
|
|
(400,142 |
) |
|
Repurchase of common stock |
|
— |
|
|
|
(7,622 |
) |
|
|
(60,000 |
) |
|
|
(50,000 |
) |
|
Payments for taxes related to net share settlement of equity awards |
|
— |
|
|
|
(3 |
) |
|
|
(230 |
) |
|
|
(4,077 |
) |
|
Proceeds from exercise of stock options |
|
— |
|
|
|
350 |
|
|
|
225 |
|
|
|
351 |
|
|
Dividends paid to non-related party |
|
(1,927 |
) |
|
|
(1,993 |
) |
|
|
(7,770 |
) |
|
|
(7,439 |
) |
|
Dividends paid to related party |
|
(640 |
) |
|
|
(639 |
) |
|
|
(2,559 |
) |
|
|
(3,206 |
) |
|
Interest rate swap settlements |
|
2,661 |
|
|
|
(905 |
) |
|
|
6,423 |
|
|
|
(4,170 |
) |
|
Net cash used in financing activities |
|
(30 |
) |
|
|
(110,954 |
) |
|
|
(176,267 |
) |
|
|
(471,792 |
) |
|
Net change in cash and cash equivalents |
|
23,143 |
|
|
|
(28,715 |
) |
|
|
76,391 |
|
|
|
(86,612 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
2,104 |
|
|
|
(427 |
) |
|
|
736 |
|
|
|
(1,316 |
) |
|
Cash and cash equivalents at beginning of period |
|
109,394 |
|
|
|
86,656 |
|
|
|
57,514 |
|
|
|
145,442 |
|
|
Cash and cash equivalents at end of period |
$ |
134,641 |
|
|
$ |
57,514 |
|
|
$ |
134,641 |
|
|
$ |
57,514 |
|
|
|
|
|
|
|
|
|
|
|||||||||
* Net change in working capital due to changes in the following components: |
|
|
|
|
|
|
||||||||||
Accounts and notes receivable, net |
$ |
38,278 |
|
|
$ |
(25,472 |
) |
|
$ |
60,507 |
|
|
$ |
(28,927 |
) |
|
Inventories |
|
(7,078 |
) |
|
|
(20,919 |
) |
|
|
(153,579 |
) |
|
|
(28,165 |
) |
|
Prepaid expenses and other current assets |
|
(1,097 |
) |
|
|
(14,257 |
) |
|
|
593 |
|
|
|
(31,921 |
) |
|
Income taxes payable |
|
5,197 |
|
|
|
8,045 |
|
|
|
(15,029 |
) |
|
|
5,674 |
|
|
Accounts payable and accruals |
|
(27,625 |
) |
|
|
(5,157 |
) |
|
|
7,748 |
|
|
|
66,591 |
|
|
Interest payable |
|
(5,628 |
) |
|
|
(5,791 |
) |
|
|
185 |
|
|
|
371 |
|
|
Net change in working capital |
$ |
2,047 |
|
|
$ |
(63,551 |
) |
|
$ |
(99,575 |
) |
|
$ |
(16,377 |
) |
NON-GAAP RECONCILIATIONS |
||||||||||||||||
(Dollars in thousands, except per share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
The following tables reconcile our non-GAAP key financial measures to the most directly comparable GAAP measures: |
||||||||||||||||
Reconciliation of Net Income to Adjusted Net Income |
|
|
|
|||||||||||||
|
|
|
|
Year Ended |
||||||||||||
|
Q4 2022 |
Q3 2022 |
Q4 2021 |
2022 |
2021 |
|||||||||||
|
|
|
|
|
|
|||||||||||
Net income |
$ |
50,331 |
|
$ |
93,451 |
|
$ |
141,480 |
|
$ |
382,962 |
|
$ |
388,330 |
|
|
|
|
|
|
|
|
|||||||||||
Diluted income per common share: |
|
|
|
|
|
|||||||||||
Net income per share |
$ |
0.20 |
|
$ |
0.36 |
|
$ |
0.54 |
|
$ |
1.48 |
|
$ |
1.46 |
|
|
Weighted average shares outstanding |
|
256,902,385 |
|
|
256,853,454 |
|
|
263,516,311 |
|
|
258,791,228 |
|
|
266,317,194 |
|
|
|
|
|
|
|
|
|||||||||||
Adjustments, pre-tax: |
|
|
|
|
|
|||||||||||
Pension and OPEB plan (benefits) expenses(1) |
|
(8,993 |
) |
|
534 |
|
|
(3,840 |
) |
|
(7,355 |
) |
|
(2,545 |
) |
|
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
100 |
|
|
663 |
|
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
819 |
|
|
(532 |
) |
|
(484 |
) |
|
521 |
|
|
(119 |
) |
|
Stock-based compensation expense(4) |
|
645 |
|
|
628 |
|
|
337 |
|
|
2,311 |
|
|
1,917 |
|
|
Non-cash fixed asset write-off(5) |
|
1,068 |
|
|
— |
|
|
2,884 |
|
|
1,068 |
|
|
3,197 |
|
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
97 |
|
|
— |
|
|
184 |
|
|
(83 |
) |
|
231 |
|
|
Change in Control LTIP award(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
73,384 |
|
|
Change in Control stock-based compensation acceleration(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
14,713 |
|
|
|
|
— |
|
|
— |
|
|
(11,511 |
) |
|
— |
|
|
(11,511 |
) |
|
Total non-GAAP adjustments pre-tax |
|
(6,364 |
) |
|
630 |
|
|
(12,430 |
) |
|
(3,438 |
) |
|
79,930 |
|
|
Income tax impact on non-GAAP adjustments(9) |
|
(794 |
) |
|
198 |
|
|
(2,130 |
) |
|
(142 |
) |
|
3,675 |
|
|
Adjusted net income |
$ |
44,761 |
|
$ |
93,883 |
|
$ |
131,180 |
|
$ |
379,666 |
|
$ |
464,585 |
|
(1) |
Net periodic benefit (credit) cost for our pension and OPEB plans, including a mark-to-market (gain) loss, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash losses (gains) from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-initial public offering ("IPO") stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
|
(8) |
Gain from the settlement of a value-added tax matter in |
|
(9) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
Reconciliation of EPS to Adjusted EPS |
|
|
|
||||||||||||
|
|
|
|
Year Ended |
|||||||||||
|
Q4 2022 |
Q3 2022 |
Q4 2021 |
2022 |
2021 |
||||||||||
|
|
|
|
|
|
||||||||||
EPS |
$ |
0.20 |
|
$ |
0.36 |
$ |
0.54 |
|
$ |
1.48 |
|
$ |
1.46 |
|
|
Adjustments per share: |
|
|
|
|
|
||||||||||
Pension and OPEB plan (benefits) expenses(1) |
|
(0.04 |
) |
|
— |
|
(0.02 |
) |
|
(0.03 |
) |
|
(0.01 |
) |
|
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
— |
|
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
— |
|
|
Stock-based compensation expense(4) |
|
— |
|
|
0.01 |
|
— |
|
|
0.01 |
|
|
— |
|
|
Non-cash fixed asset write-off(5) |
|
0.01 |
|
|
— |
|
0.01 |
|
|
0.01 |
|
|
0.01 |
|
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
— |
|
|
Change in Control LTIP award(7) |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
0.27 |
|
|
Change in Control stock-based compensation acceleration(7) |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
0.06 |
|
|
|
|
— |
|
|
— |
|
(0.04 |
) |
|
— |
|
|
(0.04 |
) |
|
Total non-GAAP adjustments pre-tax per share |
|
(0.03 |
) |
|
0.01 |
|
(0.05 |
) |
|
(0.01 |
) |
|
0.29 |
|
|
Income tax impact on non-GAAP adjustments per share(9) |
|
— |
|
|
— |
|
(0.01 |
) |
|
— |
|
|
0.01 |
|
|
Adjusted EPS |
$ |
0.17 |
|
$ |
0.37 |
$ |
0.50 |
|
$ |
1.47 |
|
$ |
1.74 |
|
(1) |
Net periodic benefit (credit) cost for our pension and OPEB plans, including a mark-to-market (gain) loss, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash losses (gains) from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
|
(8) |
Gain from the settlement of a value-added tax matter in |
|
(9) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
Reconciliation of Net Income to EBITDA and Adjusted EBITDA |
|
|
|||||||||||||
|
|
|
|
Year Ended |
|||||||||||
|
Q4 2022 |
Q3 2022 |
Q4 2021 |
2022 |
2021 |
||||||||||
|
|
|
|
|
|
||||||||||
Net income |
$ |
50,331 |
|
$ |
93,451 |
|
$ |
141,480 |
|
$ |
382,962 |
|
$ |
388,330 |
|
Add: |
|
|
|
|
|
||||||||||
Depreciation and amortization |
|
13,788 |
|
|
13,262 |
|
|
17,301 |
|
|
55,496 |
|
|
65,716 |
|
Interest expense |
|
11,533 |
|
|
6,424 |
|
|
14,551 |
|
|
36,568 |
|
|
68,760 |
|
Interest income |
|
(2,283 |
) |
|
(241 |
) |
|
(219 |
) |
|
(4,480 |
) |
|
(872 |
) |
Income taxes |
|
13,096 |
|
|
15,041 |
|
|
22,134 |
|
|
69,356 |
|
|
68,076 |
|
EBITDA |
|
86,465 |
|
|
127,937 |
|
|
195,247 |
|
|
539,902 |
|
|
590,010 |
|
Adjustments: |
|
|
|
|
|
||||||||||
Pension and OPEB plan (benefits) expenses(1) |
|
(8,993 |
) |
|
534 |
|
|
(3,840 |
) |
|
(7,355 |
) |
|
(2,545 |
) |
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
100 |
|
|
663 |
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
819 |
|
|
(532 |
) |
|
(484 |
) |
|
521 |
|
|
(119 |
) |
Stock-based compensation expense(4) |
|
645 |
|
|
628 |
|
|
337 |
|
|
2,311 |
|
|
1,917 |
|
Non-cash fixed asset write-off(5) |
|
1,068 |
|
|
— |
|
|
2,884 |
|
|
1,068 |
|
|
3,197 |
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
97 |
|
|
— |
|
|
184 |
|
|
(83 |
) |
|
231 |
|
Change in Control LTIP award(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
73,384 |
|
Change in Control stock-based compensation acceleration(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
14,713 |
|
|
|
— |
|
|
— |
|
|
(11,511 |
) |
|
— |
|
|
(11,511 |
) |
Adjusted EBITDA |
$ |
80,101 |
|
$ |
128,567 |
|
$ |
182,817 |
|
$ |
536,464 |
|
$ |
669,940 |
|
(1) |
Net periodic benefit (credit) cost for our pension and OPEB plans, including a mark-to-market (gain) loss, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash losses (gains) from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
|
(8) |
Gain from the settlement of a value-added tax matter in |
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow and Adjusted Free Cash Flow |
|||||||||||||||
|
|
|
|
Year Ended |
|||||||||||
|
Q4 2022 |
Q3 2022 |
Q4 2021 |
2022 |
2021 |
||||||||||
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities |
$ |
50,023 |
|
$ |
68,166 |
|
$ |
100,029 |
|
$ |
324,628 |
|
$ |
443,040 |
|
Capital expenditures |
|
(26,884 |
) |
|
(15,933 |
) |
|
(17,831 |
) |
|
(72,165 |
) |
|
(58,257 |
) |
Free cash flow |
|
23,139 |
|
|
52,233 |
|
|
82,198 |
|
|
252,463 |
|
|
384,783 |
|
Change in Control payment(1) |
|
— |
|
|
— |
|
|
4,659 |
|
|
443 |
|
|
71,377 |
|
Adjusted free cash flow |
$ |
23,139 |
|
$ |
52,233 |
|
$ |
86,857 |
|
$ |
252,906 |
|
$ |
456,160 |
|
(1) |
In the second quarter of 2021, we incurred pre-tax Change in Control charges of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005800/en/
216-676-2000
investor.relations@graftech.com
Source:
FAQ
What were GrafTech's Q4 2022 earnings per share?
How much did GrafTech's net income drop in Q4 2022?
What was the sales volume for GrafTech in Q4 2022?
What are GrafTech's expectations for 2023 sales volume?